Search

Skip to main content Emerging Blood-based Biomarkers for HCC Screening Blood-based biomarkers offer a non-invasive, scalable strategy for HCC screening that can increase sensitivity for early-stage HCC as well as adherence. Tests like GALAD and methylated DNA panels have shown promise in improving se…

Skip to main content Cost Effectiveness of HCC screening We have conducted cost-effectiveness studies showing that screening is cost-effective compared to no screening. We have also shown that biomarker-based screening would be cost-effective, depending on utilization, costs of tests, and sensitivity…

Invited Review in Frontiers Immunology - Metastatic Latency

Malladi Lab at the San Antonio Breast Cancer Symposium 2021.

Skip to main content HCC Screening Utilization and Interventions We have shown that despite clear guidelines, HCC screening remains underutilized. We have conducted multi-center survey studies to identify relevant barriers including provider knowledge gaps, patient misconceptions, and systemic ineffi…

Learn about the Luo (Weibo) Lab's research.

Best Poster Awarded to Pravat at National Postdoctoral Appreciation Week Research Symposium

Luo (Weibo) Lab publications.

A list of publications by Paulo E. A. Kuriki, MD

Join the Yan Lab.